Prevention Works Best in Pairs: An Observational Study on Connubial Melanoma
Abstract
1. Introduction
2. Patients and Methods
2.1. Study Design and Setting
2.2. Inclusion Criteria
2.3. Clinical and Dermatological Assessment
2.4. Variables Analyzed
2.5. Statistical Analysis
3. Results
3.1. Study Population
3.2. Comparison of Risk Factors Between Spouses
3.3. Phototype, Tanning Bed Use, and Sunburn History
3.4. Stage and Anatomical Distribution of Melanoma
3.5. Initiative in Seeking Dermatological Evaluation
4. Discussion
Study Limitations
5. Conclusions
Author Contributions
Funding
Institutional Review Board Statement
Informed Consent Statement
Data Availability Statement
Acknowledgments
Conflicts of Interest
References
- Rawlik, K.; Canela-Xandri, O.; Tenesa, A. Indirect assortative mating for human disease and longevity. Heredity (Edinb) 2019, 123, 106–116. [Google Scholar] [CrossRef] [PubMed]
- De Simone, P.; Bottillo, I.; Valiante, M.; Iorio, A.; De Bernardo, C.; Majore, S.; D’Angelantonio, D.; Valentini, T.; Sperduti, I.; Piemonte, P.; et al. A Single Center Retrospective Review of Patients from Central Italy Tested for Melanoma Predisposition Genes. Int. J. Mol. Sci. 2020, 21, 9432. [Google Scholar] [CrossRef] [PubMed]
- D’Ecclesiis, O.; Caini, S.; Martinoli, C.; Raimondi, S.; Gaiaschi, C.; Tosti, G.; Queirolo, P.; Veneri, C.; Saieva, C.; Gandini, S.; et al. Gender-Dependent Specificities in Cutaneous Melanoma Predisposition, Risk Factors, Somatic Mutations, Prognostic and Predictive Factors: A Systematic Review. Int. J. Environ. Res. Public Health 2021, 18, 7945. [Google Scholar] [CrossRef] [PubMed]
- Campisi, G.; Buttacavoli, F.; Attanasio, M.; Milioto, M.; Radosti, S.; Amato, S.; Panzarella, V. Gender and Sex in Medical Practice: An Exploratory Study on Knowledge, Behavior, and Attitude among Sicilian Physicians. Int. J. Environ. Res. Public Health 2023, 20, 827. [Google Scholar] [CrossRef] [PubMed]
- Teixido, C.; Castillo, P.; Martinez-Vila, C.; Arance, A.; Alos, L. Molecular Markers and Targets in Melanoma. Cells 2021, 10, 2320. [Google Scholar] [CrossRef] [PubMed]
- Dzwierzynski, W.W. Melanoma risk factors and prevention. Clin. Plast. Surg. 2021, 48, 543–550. [Google Scholar] [CrossRef] [PubMed]
- Conforti, C.; Zalaudek, I. Epidemiology and risk factors of melanoma: A review. Dermatol. Pract. Concept. 2021, 11 (Suppl. 1), e2021161S. [Google Scholar] [CrossRef] [PubMed]
- Russo, T.; Corneli, P.; Piccolo, V.; Zalaudek, I.; Alfano, R.; Argenziano, G. Saint Valentine’s melanoma. J. Eur. Acad. Dermatol. Venereol. 2019, 33, e179–e180. [Google Scholar] [CrossRef] [PubMed]
- Raimondi, S.; Suppa, M.; Gandini, S. Melanoma epidemiology and sun exposure. Acta Derm.-Venereol. 2020, 100, adv00136. [Google Scholar] [CrossRef] [PubMed]
- Rodriguez-Acevedo, A.J.; Green, A.C.; Sinclair, C.; van Deventer, E.; Gordon, L.G. Indoor tanning prevalence after the International Agency for Research on Cancer statement on carcinogenicity of artificial tanning devices: Systematic review and meta-analysis. Br. J. Dermatol. 2020, 182, 849–859. [Google Scholar] [CrossRef] [PubMed]
- Guerra, N.L.; Matas-García, A.; Serra-García, L.; Morgado-Carrasco, D.; Padrosa, J.; Aldecoa, I.; Duque, Y.; Casal-Dominguez, M.; Muñoz-Braceras, S.; Aranega, R.; et al. Dermatomyositis unleashed by immune checkpoint inhibitors. Three additional cases and a review of the literature. Autoimmun. Rev. 2023, 22, 103375. [Google Scholar] [CrossRef] [PubMed]
- Buja, A.; Rugge, M.; Damiani, G.; Zorzi, M.; De Toni, C.; Vecchiato, A.; Del Fiore, P.; Spina, R.; Baldo, V.; Brazzale, A.R.; et al. Sex Differences in Cutaneous Melanoma: Incidence, Clinicopathological Profile, Survival, and Costs. J. Womens Health 2022, 31, 1012–1019. [Google Scholar] [CrossRef] [PubMed]
- Newell, G.R.; Sider, J.G.; Bergfelt, L.; Kripke, M.L. Incidence of cutaneous melanoma in the United States by histology with special reference to the face. Cancer Res. 1988, 48, 5036–5041. [Google Scholar] [PubMed]
- Oliveria, S.A.; Shuk, E.; Hay, J.L.; Heneghan, M.; Goulart, J.M.; Panageas, K.; Geller, A.C.; Halpern, A.C. Melanoma survivors: Health behaviors, surveillance, psychosocial factors, and family concerns. Psychooncology 2013, 22, 106–116. [Google Scholar] [CrossRef] [PubMed]
- Chen, Z.H.; Yang, K.B.; Zhang, Y.Z.; Wu, C.F.; Wen, D.W.; Lv, J.W.; Zhu, G.L.; Du, X.J.; Chen, L.; Zhou, G.Q.; et al. Assessment of Modifiable Factors for the Association of Marital Status With Cancer-Specific Survival. JAMA Netw. Open 2021, 4, e2111813. [Google Scholar] [CrossRef] [PubMed]
- McLaughlin, J.M.; Fisher, J.L.; Paskett, E.D. Marital status and stage at diagnosis of cutaneous melanoma: Results from the Surveillance Epidemiology and End Results (SEER) program, 1973–2006. Cancer 2011, 117, 1984–1993. [Google Scholar] [CrossRef] [PubMed]
- Linos, K.; Slominski, A.; Ross, J.S.; Carlson, J.A. Melanoma update: Diagnostic and prognostic factors that can effectively shape and personalize management. Biomark. Med. 2011, 5, 333–360. [Google Scholar] [CrossRef] [PubMed]
Variable | Husbands (n = 52) | Wives (n = 52) | χ2 Test (p-Value) | ||
---|---|---|---|---|---|
Exposure to artificial UV sources | n (%) | 95% CI | n (%) | 95% CI | |
| 42 (80.8%) | 0.69–0.90 | 25 (48.1%) | 0.37–0.63 | <0.001 |
| 10 (19.2%) | 0.10–0.31 | 27 (51.9%) | 0.37–0.63 | |
History of sunburns | |||||
| 10 (19.2%) | 0.10–0.31 | 14 (26.9%) | 0.16–0.39 | 0.352 |
| 42 (80.8%) | 0.69–0.90 | 38 (73.1%) | 0.61–0.84 | |
Presence of multiple nevi | |||||
| 22 (42.3%) | 0.29–0.54 | 25 (48.1%) | 0.37–0.63 | 0.554 |
| 30 (57.7%) | 0.46–0.71 | 27 (51.9%) | 0.37–0.63 | |
Phototype | 0.718 | ||||
| 5 (9.6%) | 0.04–0.20 | 5 (9.6%) | 0.04–0.20 | |
| 23 (44.3%) | 0.30–0.56 | 27 (51.9%) | 0.41–0.66 | |
| 18 (34.6%) | 0.25–0.50 | 17 (32.7%) | 0.21–0.45 | |
| 6 (11.5%) | 0.05–0.22 | 3 (5.8%) | 0.02–0.15 |
Phototype | Overall (n = 104) | Husbands (n = 52) | Wives (n = 52) | ||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
n (%) | 95% CI | n (%) | 95% CI | n (%) | 95% CI | n (%) | 95% CI | n (%) | 95% CI | n (%) | 95% CI | ||
Phototype by use of artificial UV sources | No (n = 67) | Yes (n = 37) | No (n = 42) | Yes (n = 10) | No (n = 25) | Yes (n = 27) | |||||||
| 5 (7.5%) | 0.03–0.15 | 5 (13.5%) | 0.06–0.28 | 3 (7.1%) | 0.02–0.18 | 2 (20.0%) | 0.06–0.51 | 2 (8.0%) | 0.02–0.23 | 3 (11.1%) | 0.04–0.28 | |
| 25 (37.3%) | 0.28–0.50 | 25 (67.6%) | 0.51–0.80 | 17 (40.5%) | 0.26–0.53 | 6 (60.0%) | 0.31–0.83 | 8 (32.0%) | 0.21–0.56 | 19 (70.4%) | 0.51–0.84 | |
| 29 (43.3%) | 0.33–0.55 | 6 (16.2%) | 0.08–0.31 | 16 (38.1%) | 0.28–0.55 | 2 (20.0%) | 0.06–0.51 | 13 (52.0%) | 0.31–0.66 | 4 (14.8%) | 0.06–0.32 | |
| 8 (11.9%) | 0.06–0.21 | 1 (2.7%) | 0.00–0.14 | 6 (14.3%) | 0.06–0.27 | 0 (0.0%) | 0.00–0.28 | 2 (8.0%) | 0.02–0.23 | 1 (3.7%) | 0.01–0.18 | |
| 0.005 | 0.233 | 0.021 | ||||||||||
Phototype by history of sunburns | No (n = 24) | Yes (n = 80) | No (n = 10) | Yes (n = 42) | No (n = 14) | Yes (n = 38) | |||||||
| 0 (0.0%) | 0.00–0.14 | 10 (12.5%) | 0.07–0.20 | 0 (0.0%) | 0.00–0.28 | 5 (11.9%) | 0.05–0.24 | 0 (0.0%) | 0.00–0.21 | 5 (13.2%) | 0.05–0.26 | |
| 0 (0.0%) | 0.0–0.14 | 50 (62.5%) | 0.51–0.71 | 0 (0.0%) | 0.00–0.28 | 23 (54.8%) | 0.38–0.66 | 0 (0.0%) | 0.00–0.21 | 27 (71.0%) | 0.57–0.84 | |
| 17 (70.8%) | 0.51–0.85 | 18 (22.5%) | 0.16–0.34 | 5 (50.0%) | 0.24–0.76 | 13 (30.9%) | 0.22–0.49 | 12 (85.7%) | 0.60–0.96 | 5 (13.2%) | 0.05–0.26 | |
| 7 (29.2%) | 0.15–0.49 | 2 (2.5%) | 0.01–0.08 | 5 (50.0%) | 0.24–0.76 | 1 (2.4%) | 0.00–0.12 | 2 (14.3%) | 0.04–0.40 | 1 (2.6%) | 0.00–0.13 | |
p-value | <0.001 | <0.001 | <0.001 |
Variable | Husbands (n = 52) | Wives (n = 52) | ||
---|---|---|---|---|
Tumor stage | n (%) | 95% CI | n (%) | 95% CI |
| 23 (44.3%) | 0.31–0.57 | 32 (61.5%) | 0.47–0.72 |
| 21 (40.4%) | 0.29–0.55 | 17 (32.7%) | 0.23–0.47 |
| 5 (9.6%) | 0.04–0.20 | 3 (5.8%) | 0.02–0.15 |
| 2 (3.8%) | 0.01–0.13 | 0 (0.0%) | 0.00–0.07 |
| 1 (1.9%) | 0.00–0.10 | 0 (0.0%) | 0.00–0.07 |
Total (p = 0.249) | 52 (100%) | 52 (100%) | ||
Anatomical site | ||||
| 33 (63.4%) | 0.51–0.76 | 10 (19.2%) | 0.12–0.33 |
| 11 (21.2%) | 0.12–0.33 | 35 (67.4%) | 0.52–0.77 |
| 3 (5.8%) | 0.02–0.15 | 1 (1.9%) | 0.00–0.10 |
| 5 (9.6%) | 0.04–0.20 | 6 (11.5%) | 0.05–0.22 |
Total (p < 0.001) | 52 (100%) | 52 (100%) |
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content. |
© 2025 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
Share and Cite
Iorio, A.; Fargnoli, M.C.; Sperati, F.; Frascione, P.; De Simone, P. Prevention Works Best in Pairs: An Observational Study on Connubial Melanoma. Diagnostics 2025, 15, 1869. https://doi.org/10.3390/diagnostics15151869
Iorio A, Fargnoli MC, Sperati F, Frascione P, De Simone P. Prevention Works Best in Pairs: An Observational Study on Connubial Melanoma. Diagnostics. 2025; 15(15):1869. https://doi.org/10.3390/diagnostics15151869
Chicago/Turabian StyleIorio, Alessandra, Maria Concetta Fargnoli, Francesca Sperati, Pasquale Frascione, and Paola De Simone. 2025. "Prevention Works Best in Pairs: An Observational Study on Connubial Melanoma" Diagnostics 15, no. 15: 1869. https://doi.org/10.3390/diagnostics15151869
APA StyleIorio, A., Fargnoli, M. C., Sperati, F., Frascione, P., & De Simone, P. (2025). Prevention Works Best in Pairs: An Observational Study on Connubial Melanoma. Diagnostics, 15(15), 1869. https://doi.org/10.3390/diagnostics15151869